title: [Systemic sclerosis: drugs and new therapeutic methods].
abstract: The purpose of our review is to present conventional drugs as well as innovative treatment concepts for systemic sclerosis, particularly with their effects on the most important pathogenetic mechanisms of this disease. Date from literature indicates that all therapeutic methods are connected with occurrence of side effects, therefore in our paper we focused on benefits and disadvantages of therapeutic options for systemic sclerosis.
authors.affiliation: Zakład Farmakologii Katedry Farmakologii Akademii Medycznej w Łodzi.
authors.forename: Kamila
authors.initials: K
authors.lastname: Skretkowicz
authors.forename: Elzbieta
authors.initials: E
authors.lastname: Waszczykowska
authors.forename: Bozena
authors.initials: B
authors.lastname: Dziankowska-Bartkowiak
mesh_terms: D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D007371:Interferon-gamma; D010406:Penicillins; D017367:Selective Serotonin Reuptake Inhibitors; D013792:Thalidomide